EUS-RFA may be a safe and potentially effective treatment option in selected patients with benign solid pancreatic tumors. Multiple sessions may be required if there is a remnant tumor, and adverse events must be carefully monitored.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: